PRS
INFI

Pinkerton Retirement Specialists’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Pinkerton Retirement Specialists’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-44
Closed – – 526
2016
Q4 		$0 Hold
44
– – ﹤0.01% 660
2016
Q3 		$0 Hold
44
– – ﹤0.01% 672
2016
Q2 		$0 Buy
+44
New +$206 ﹤0.01% 663

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Pinkerton Retirement Specialists's INFI Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2017, closing a stake of 44 shares.

Pinkerton Retirement Specialists first reported a position in INFI in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 80 funds tracked by Wall St. Rank hold INFI as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 44 Infinity Pharmaceuticals, Inc. shares in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Infinity Pharmaceuticals, Inc. position peaked at $0 in Q4 2016.
  • 80 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.